PRICE T ROWE ASSOCIATES INC /MD/ - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$187
-53.0%
110,512
-22.5%
0.00%
Q2 2023$398
+30.9%
142,540
-14.5%
0.00%
Q1 2023$304
-60.0%
166,758
+11.2%
0.00%
Q4 2022$760
-99.9%
149,958
-5.0%
0.00%
Q3 2022$785,000
+43.8%
157,866
+7.6%
0.00%
Q2 2022$546,000
-41.0%
146,717
-11.1%
0.00%
Q1 2022$926,000
-20.4%
165,121
-13.7%
0.00%
Q4 2021$1,164,000
-34.4%
191,402
+5.1%
0.00%
Q3 2021$1,774,000
-42.2%
182,102
-15.3%
0.00%
Q2 2021$3,070,000
-36.3%
215,008
+5.9%
0.00%
Q1 2021$4,818,000202,9380.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders